We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$778M
AUM Growth
-$1.85M
Cap. Flow
-$35.3M
Cap. Flow %
-4.54%
Top 10 Hldgs %
34.42%
Holding
5,522
New
920
Increased
1,531
Reduced
1,579
Closed
1,330

Sector Composition

Rank Sector Weight
1 Industrials 6%
2 Financials 5.45%
3 Technology 5.24%
4 Consumer Discretionary 4.75%
5 Healthcare 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSV icon
1701
Carriage Services
CSV
$641M
$25K ﹤0.01%
1,488
+890
+149% +$15.3K
EDD
1702
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
$25K ﹤0.01%
+1,909
New +$25.5K
ESCA icon
1703
Escalade
ESCA
$302M
$25K ﹤0.01%
1,525
+813
+114% +$12.4K
EUFN icon
1704
iShares MSCI Europe Financials ETF
EUFN
$4.27B
$25K ﹤0.01%
+1,026
New +$26.3K
FARM
1705
DELISTED
Farmer Brothers
FARM
$25K ﹤0.01%
1,135
-2,852
-72% -$57.3K
GRID
1706
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12.1B
$25K ﹤0.01%
664
+40
+6% +$1.51K
NVEE
1707
DELISTED
NV5 Global
NVEE
$25K ﹤0.01%
10,268
+2,544
+33% +$6.28K
PHX
1708
DELISTED
PHX Minerals
PHX
$25K ﹤0.01%
880
+14
+2% +$353
REGN icon
1709
Regeneron Pharmaceuticals
REGN
$79.8B
$25K ﹤0.01%
+90
New +$26.7K
TV icon
1710
Televisa
TV
$1.45B
$25K ﹤0.01%
738
+464
+169% +$15.6K
CSCI
1711
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$25K ﹤0.01%
2
-2
-50% -$22.3K
MRTX
1712
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$25K ﹤0.01%
1,232
-1,446
-54% -$27.9K
SPPI
1713
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$25K ﹤0.01%
3,057
-2,810
-48% -$21.3K
CHKR
1714
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
$25K ﹤0.01%
+2,280
New +$24.7K
DYN
1715
DELISTED
Dynegy, Inc.
DYN
$25K ﹤0.01%
729
-7,619
-91% -$235K
CWEI
1716
DELISTED
Clayton Williams Energy, Inc.
CWEI
$25K ﹤0.01%
+180
New +$23.1K
CBR
1717
DELISTED
CIBER Inc.
CBR
$25K ﹤0.01%
5,005
-964
-16% -$4.36K
LIOX
1718
DELISTED
Lionbridge Technologies
LIOX
$25K ﹤0.01%
4,224
-14,426
-77% -$84.6K
CSH
1719
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
$25K ﹤0.01%
1,236
+994
+411% +$20K
ENZN
1720
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$25K ﹤0.01%
24,314
+7,468
+44% +$7.12K
CHDX
1721
DELISTED
CHINDEX INTL INC
CHDX
$25K ﹤0.01%
1,076
-2,133
-66% -$49.2K
AMNB
1722
DELISTED
American National Bankshares Inc
AMNB
$25K ﹤0.01%
1,156
-1,339
-54% -$29.4K
BSQR
1723
DELISTED
BSQUARE Corporation
BSQR
$25K ﹤0.01%
7,749
+2,422
+45% +$7.89K
BDX icon
1724
Becton Dickinson
BDX
$46.8B
$24K ﹤0.01%
208
+149
+253% +$16.9K
CASH icon
1725
Pathward Financial
CASH
$1.89B
$24K ﹤0.01%
1,737
+1,407
+426% +$18.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2014 Portfolio in Review

As of Q2 2014, Tower Research Capital (TRC) held 5,522 positions worth $778M, down 0.24% from $780M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $35.3M in Q2 2014, closing 1,330 positions and reducing 1,579 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $9.03M.

  • Tower Research Capital (TRC)'s largest Q2 2014 buy was iShares Russell 1000 Value ETF: 89,185 shares worth $9.03M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $177M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2014 reduction was Invesco QQQ Trust, cutting an estimated $110M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Small-Cap ETF in Q2 2014, selling an estimated $10.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $778M portfolio in Q2 2014.
  • Tower Research Capital (TRC) opened 920 new positions and closed 1,330 in Q2 2014.
  • Tower Research Capital (TRC)'s portfolio value fell 0.24% quarter-over-quarter to $778M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.